These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 29895742)
1. Polyamidoamine Dendrimers for Enhanced Solubility of Small Molecules and Other Desirable Properties for Site Specific Delivery: Insights from Experimental and Computational Studies. Shadrack DM; Swai HS; Munissi JJE; Mubofu EB; Nyandoro SS Molecules; 2018 Jun; 23(6):. PubMed ID: 29895742 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of polyamidoamine dendrimers as potential carriers for quercetin, a versatile flavonoid. Madaan K; Lather V; Pandita D Drug Deliv; 2016; 23(1):254-62. PubMed ID: 24845475 [TBL] [Abstract][Full Text] [Related]
3. Polyamidoamine dendrimers used as solubility enhancers of ketoprofen. Yiyun C; Tongwen X; Rongqiang F Eur J Med Chem; 2005 Dec; 40(12):1390-3. PubMed ID: 16226353 [TBL] [Abstract][Full Text] [Related]
4. PAMAM dendrimers for the delivery of the antibacterial Triclosan. Gardiner J; Freeman S; Leach M; Green A; Alcock J; D'Emanuele A J Enzyme Inhib Med Chem; 2008 Oct; 23(5):623-8. PubMed ID: 18821252 [TBL] [Abstract][Full Text] [Related]
5. Dendrimers as potential drug carriers. Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers. Yiyun C; Tongwen X Eur J Med Chem; 2005 Nov; 40(11):1188-92. PubMed ID: 16153746 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug. Ma M; Cheng Y; Xu Z; Xu P; Qu H; Fang Y; Xu T; Wen L Eur J Med Chem; 2007 Jan; 42(1):93-8. PubMed ID: 17095123 [TBL] [Abstract][Full Text] [Related]
7. Polyamidoamine Starburst dendrimers as solubility enhancers. Milhem OM; Myles C; McKeown NB; Attwood D; D'Emanuele A Int J Pharm; 2000 Mar; 197(1-2):239-41. PubMed ID: 10704811 [TBL] [Abstract][Full Text] [Related]
8. Solubility of nicotinic acid in polyamidoamine dendrimer solutions. Yiyun C; Tongwen X Eur J Med Chem; 2005 Dec; 40(12):1384-9. PubMed ID: 16226352 [TBL] [Abstract][Full Text] [Related]
9. [The effect of polyamidoamine (PAMAM) dendrimers on the solubility and pharmacokinetics of breviscapine]. Lu JJ; Wu ZH; Ping QN Yao Xue Xue Bao; 2009 Feb; 44(2):197-202. PubMed ID: 19408693 [TBL] [Abstract][Full Text] [Related]
10. Polypropyleneimine and polyamidoamine dendrimer mediated enhanced solubilization of bortezomib: Comparison and evaluation of mechanistic aspects by thermodynamics and molecular simulations. Chaudhary S; Gothwal A; Khan I; Srivastava S; Malik R; Gupta U Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():611-619. PubMed ID: 28024628 [TBL] [Abstract][Full Text] [Related]
11. Polyamidomine dendrimers: an excellent drug carrier for improving the solubility and bioavailability of puerarin. Gu L; Wu Zh; Qi X; He H; Ma X; Chou X; Wen X; Zhang M; Jiao F Pharm Dev Technol; 2013; 18(5):1051-7. PubMed ID: 22303809 [TBL] [Abstract][Full Text] [Related]
12. A comparative study on solubility improvement of tetracycline and dexamethasone by poly(propylene imine) and polyamidoamine dendrimers: An insight into cytotoxicity and cell proliferation. Najafi F; Salami-Kalajahi M; Roghani-Mamaqani H; Kahaie-Khosrowshahi A J Biomed Mater Res A; 2020 Mar; 108(3):485-495. PubMed ID: 31682311 [TBL] [Abstract][Full Text] [Related]
13. Association of the anti-tuberculosis drug rifampicin with a PAMAM dendrimer. Bellini RG; Guimarães AP; Pacheco MA; Dias DM; Furtado VR; de Alencastro RB; Horta BA J Mol Graph Model; 2015 Jul; 60():34-42. PubMed ID: 26093506 [TBL] [Abstract][Full Text] [Related]
14. Computationally efficient methodology for atomic-level characterization of dendrimer-drug complexes: a comparison of amine- and acetyl-terminated PAMAM. Vergara-Jaque A; Comer J; Monsalve L; González-Nilo FD; Sandoval C J Phys Chem B; 2013 Jun; 117(22):6801-13. PubMed ID: 23642174 [TBL] [Abstract][Full Text] [Related]
15. Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery. Gu Z; Wang M; Fang Q; Zheng H; Wu F; Lin D; Xu Y; Jin Y Drug Dev Ind Pharm; 2015 May; 41(5):812-8. PubMed ID: 24745851 [TBL] [Abstract][Full Text] [Related]
16. Use of Polyamidoamine Dendrimers in Brain Diseases. Florendo M; Figacz A; Srinageshwar B; Sharma A; Swanson D; Dunbar GL; Rossignol J Molecules; 2018 Sep; 23(9):. PubMed ID: 30177605 [TBL] [Abstract][Full Text] [Related]
17. In vitro gene delivery using polyamidoamine dendrimers with a trimesyl core. Zhang XQ; Wang XL; Huang SW; Zhuo RX; Liu ZL; Mao HQ; Leong KW Biomacromolecules; 2005; 6(1):341-50. PubMed ID: 15638538 [TBL] [Abstract][Full Text] [Related]
18. Role of generation on folic acid-modified poly(amidoamine) dendrimers for targeted delivery of baicalin to cancer cells. Lv T; Yu T; Fang Y; Zhang S; Jiang M; Zhang H; Zhang Y; Li Z; Chen H; Gao Y Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():182-190. PubMed ID: 28415453 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrins. Devarakonda B; Hill RA; Liebenberg W; Brits M; de Villiers MM Int J Pharm; 2005 Nov; 304(1-2):193-209. PubMed ID: 16198076 [TBL] [Abstract][Full Text] [Related]
20. The interaction mechanism between lipopeptide (daptomycin) and polyamidoamine (PAMAM) dendrimers. Chanvorachote B; Qiu J; Muangsiri W; Nimmannit U; Kirsch LE J Pept Sci; 2015 Apr; 21(4):312-9. PubMed ID: 25694356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]